Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
China flag China · Delayed Price · Currency is CNY
13.01
-0.16 (-1.21%)
Mar 13, 2026, 4:00 PM EDT

SHA:688203 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
35.543.5547.0435.27
Depreciation & Amortization
65.4254.6842.8837.06
Other Amortization
0.08---
Loss (Gain) From Sale of Assets
-0.03--5.130.62
Asset Writedown & Restructuring Costs
0.540.970.010.3
Loss (Gain) From Sale of Investments
--0.271.09-0.19
Provision & Write-off of Bad Debts
1.510.890.33-
Other Operating Activities
8.935.682.9912.07
Change in Accounts Receivable
-85.65-66.57-33.19-2.06
Change in Inventory
-18.48-9.81-15.16-48.45
Change in Accounts Payable
32.44134.5295.3436.58
Operating Cash Flow
38.84163.03136.1571.18
Operating Cash Flow Growth
-76.18%19.75%91.27%148.37%
Capital Expenditures
-293.18-214.11-225.27-309.44
Sale of Property, Plant & Equipment
--78.430.04
Investment in Securities
--42-42
Other Investing Activities
-0.31-0.22-0.33
Investing Cash Flow
-293.18-213.8-105.07-351.72
Long-Term Debt Issued
114.1136.41178.07315.24
Short-Term Debt Repaid
-4.93---
Long-Term Debt Repaid
-180.73-151.24-292.88-357.2
Total Debt Repaid
-185.66-151.24-292.88-357.2
Net Debt Issued (Repaid)
-71.56-14.83-114.8-41.96
Issuance of Common Stock
--778.33-
Repurchase of Common Stock
-9---
Common Dividends Paid
-23.59-23.33-15.83-14.44
Other Financing Activities
12.84--14.1-10.1
Financing Cash Flow
-91.31-38.16633.6-66.51
Foreign Exchange Rate Adjustments
2.121.787.93-1.34
Net Cash Flow
-343.53-87.15672.6-348.39
Free Cash Flow
-254.34-51.08-89.13-238.26
Free Cash Flow Margin
-30.09%-6.78%-14.72%-40.73%
Free Cash Flow Per Share
-1.25-0.25-0.53-1.55
Cash Income Tax Paid
9.4721.44-13.11-20.84
Levered Free Cash Flow
-231.09-96.56-153.45-423.21
Unlevered Free Cash Flow
-226.35-91.88-147.43-416.48
Change in Working Capital
-73.1157.5346.94-13.95
Source: S&P Global Market Intelligence. Standard template. Financial Sources.